PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNova Laboratories
Nova Laboratories
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
JayempiAzathioprine2021-06-21
Graft rejection
,
Crohn disease
,
Multiple sclerosis
,
Rheumatoid arthritis
,
Systemic lupus erythematosus
,
Thrombocytopenic purpura idiopathic
,
Ulcerative colitis
PurixanMercaptopurine2014-04-28
Lymphoid leukemia
,
B-cell chronic lymphocytic leukemia
,
Non-hodgkin lymphoma
,
Precursor cell lymphoblastic leukemia-lymphoma
Xaluprine (previously mercaptopurine nova laboratories)Mercaptopurine2012-03-09
Lymphoid leukemia
,
B-cell chronic lymphocytic leukemia
,
Non-hodgkin lymphoma
,
Precursor cell lymphoblastic leukemia-lymphoma
XromiHydroxycarbamide, Hydroxyurea2019-07-01
Bcr-abl positive chronic myelogenous leukemia,
Brain neoplasms,
Essential thrombocythemia,
Head and neck neoplasms,
Hypereosinophilic syndrome,
Leukocytosis,
Melanoma,
Non-small-cell lung carcinoma,
Ovarian neoplasms,
Polycythemia vera,
Prostatic neoplasms,
Psoriasis,
Renal cell carcinoma,
Squamous cell carcinoma,
Uterine neoplasms
QaialdoSpironolactone2023-05-262036
Ascites,
Edema,
Essential hypertension,
Heart failure,
Hyperaldosteronism,
Liver cirrhosis,
Nephrotic syndrome,
Hirsutism,
Hypertension,
Hypokalemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Azathioprine
therapeutic equivalency
Hydroxycarbamide
sickle cell anemia
,
hemoglobin sc disease
Hydroxyurea
sickle cell anemia
,
hemoglobin sc disease
Mercaptopurine
precursor cell lymphoblastic leukemia-lymphoma
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use